Si Palmer
Veterinary Laboratories Agency
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Si Palmer.
Journal of Clinical Microbiology | 2006
Simeon Cadmus; Si Palmer; Melissa Okker; James Dale; Karen Gover; Noel H. Smith; Keith Jahans; R. Glyn Hewinson; Stephen V. Gordon
ABSTRACT To establish a molecular epidemiological baseline for the strains causing tuberculosis in Nigeria, a survey of isolates from humans and cattle was carried out. Spoligotyping and variable-number tandem-repeat analysis revealed that the majority of tuberculosis disease in humans in Ibadan, southwestern Nigeria, is caused by a single, closely related group of Mycobacterium tuberculosis strains. Using deletion typing, we show that approximately 13% of the disease in humans in this sample was caused by strains of Mycobacterium africanum and Mycobacterium bovis rather than M. tuberculosis. Molecular analysis of strains of M. bovis recovered from Nigerian cattle show that they form a group of closely related strains that show similarity to strains from neighboring Cameroon. Surprisingly, the strains of M. bovis recovered from humans do not match the molecular type of the cattle strains, and possible reasons for this are discussed. This is the first molecular analysis of M. tuberculosis complex strains circulating among humans and cattle in Nigeria, the results of which have significant implications for disease control.
Proceedings of the National Academy of Sciences of the United States of America | 2003
Noel H. Smith; James Dale; Jacqueline Inwald; Si Palmer; Stephen V. Gordon; R. Glyn Hewinson; John Maynard Smith
We have analyzed 11,500 isolates of Mycobacterium bovis (the cause of tuberculosis in cattle and other mammals) isolated in Great Britain (England, Wales and Scotland)] and characterized by spoligotype. Genetic exchange between cells is rare or absent in strains of the Mycobacterium tuberculosis complex so that, by using spoligotypes, it is possible to recognize “clones” with a recent common ancestor. The distribution of variable numbers of tandem repeats types in the most common clone in the data set is incompatible with random mutation and drift. The most plausible explanation is a series of “clonal expansions,” and this interpretation is supported by the geographical distribution of different genotypes. We suggest that the clonal expansion of a genotype is caused either by the spread of a favorable mutation, together with all other genes present in the ancestral cell in which the mutation occurred, or by the invasion of a novel geographical region by a limited number of genotypes. A similar pattern is observed in M. tuberculosis (the main cause of tuberculosis in humans). The significance of clonal expansion in other bacteria that have recombination is discussed.
Proceedings of the Royal Society of London B: Biological Sciences | 2011
Mark A. Chambers; Fiona Rogers; Richard J. Delahay; Sandrine Lesellier; Roland Ashford; Deanna Dalley; Sonya Gowtage; Dipesh Davé; Si Palmer; Jacky Brewer; T. R. Crawshaw; Richard S. Clifton-Hadley; Steve Carter; C. L. Cheeseman; Chris Hanks; Alistair Murray; Kate L. Palphramand; Stéphane Pietravalle; Graham C. Smith; Alexandra Tomlinson; Neil J. Walker; Gavin J. Wilson; Leigh A. L. Corner; Stephen Rushton; Mark Shirley; G. Gettinby; Robbie A. McDonald; R. Glyn Hewinson
Control of bovine tuberculosis (TB) in cattle has proven particularly challenging where reservoirs of infection exist in wildlife populations. In Britain and Ireland, control is hampered by a reservoir of infection in Eurasian badgers (Meles meles). Badger culling has positive and negative effects on bovine TB in cattle and is difficult, costly and controversial. Here we show that Bacillus Calmette-Guérin (BCG) vaccination of captive badgers reduced the progression, severity and excretion of Mycobacterium bovis infection after experimental challenge. In a clinical field study, BCG vaccination of free-living badgers reduced the incidence of positive serological test results by 73.8 per cent. In common with other species, BCG did not appear to prevent infection of badgers subjected to experimental challenge, but did significantly reduce the overall disease burden. BCG vaccination of badgers could comprise an important component of a comprehensive programme of measures to control bovine TB in cattle.
Journal of Clinical Microbiology | 2004
Sayera Banu; Stephen V. Gordon; Si Palmer; M. Riazul Islam; Shakeel Ahmed; Khan Mashrequl Alam; Stewart T. Cole; Roland Brosch
ABSTRACT Genotypic analysis was performed on 48 Mycobacterium tuberculosis complex strains collected from a hospital in Dhaka city. Deletion analysis showed that the isolates were all M. tuberculosis; 13 of them were found to be of the “ancestral” type, while 35 were of the “modern” type, indicating that both endemic (ancestral type) and epidemic (modern type) strains cause tuberculosis in Bangladesh. Genotyping based on the spoligotype and variable-number tandem repeats (VNTR) of mycobacterial interspersed repetitive units (MIRU) was also done. A total of 34 strains (71%) were grouped by spoligotyping into nine different clusters; the largest comprised 15 isolates of the Beijing genotype, whereas the remaining eight clusters consisted of two to five isolates. MIRU-VNTR typing detected 32 different patterns among 44 tested strains, and the 15 Beijing strains were further discriminated by MIRU-VNTR typing (7 distinct patterns for the 15 isolates). These results indicate that MIRU-VNTR typing, along with spoligotyping and deletion analysis, can be used effectively for molecular epidemiological studies to determine ongoing transmission clusters; to our knowledge, this is the first report about the type of strains prevailing in Bangladesh.
Vaccine | 2011
Sandrine Lesellier; Si Palmer; Sonya Gowtage-Sequiera; Roland Ashford; Deanna Dalley; Dipesh Davé; U. Weyer; F. Javier Salguero; Alejandro Núñez; T. R. Crawshaw; Leigh A. L. Corner; R. Glyn Hewinson; Mark A. Chambers
Mycobacterium bovis infection is widespread in Eurasian badger (Meles meles) populations in Great Britain and the Republic of Ireland where they act as a wildlife reservoir of infection for cattle. Removal of infected badgers can significantly reduce the incidence of bovine tuberculosis (TB) in local cattle herds. However, control measures based on culling of native wildlife are contentious and may even be detrimental to disease control. Vaccinating badgers with bacillus Calmette-Guerin (BCG) has been shown to be efficacious against experimentally induced TB of badgers when administered subcutaneously and orally. Vaccination may be an alternative or complementary strategy to other disease control measures. As the subcutaneous route is impractical for vaccinating wild badgers and an oral vaccine bait formulation is currently unavailable, we evaluated the intramuscular (IM) route of BCG administration. It has been demonstrated that the IM route is safe in badgers. IM administration has the practical advantage of being relatively easy to perform on trapped wild badgers without recourse to chemical immobilisation. We report the evaluation of the efficacy of IM administration of BCG Danish strain 1331 at two different doses: the dose prescribed for adult humans (2-8×10(5)colony forming units) and a 10-fold higher dose. Vaccination generated a dose-dependent cell-mediated immune response characterised by the production of interferon-γ (IFNγ) and protection against endobronchial challenge with virulent M. bovis. Protection, expressed in terms of a significant reduction in the severity of disease, the number of tissues containing acid-fast bacilli, and reduced bacterial excretion was statistically significant with the higher dose only.
Journal of Clinical Microbiology | 2007
J. Sawyer; D. Mealing; Deanna Dalley; Dipesh Davé; Sandrine Lesellier; Si Palmer; J. Bowen-Davies; T. R. Crawshaw; Mark A. Chambers
ABSTRACT A real-time PCR assay for the measurement of gamma interferon (IFN-γ) mRNA in European badger (Meles meles) blood cultures was developed. The levels of IFN-γ mRNA in blood cultures stimulated with either bovine or avian tuberculin or specific mycobacterial antigens were compared with those in a nonstimulated control blood culture as the basis for determining the tuberculosis (TB) status of live badgers. The assay was validated by testing 247 animals for which there were matching data from postmortem examination and culture of tissues. Relative changes in the levels of IFN-γ mRNA in response to bovine tuberculin and specific antigens were found to be greater among badgers with tissues positive for TB on culture. The test was at its most accurate (87% of test results were correct) by using blood cultures containing bovine tuberculin as the antigen and when the response to avian tuberculin was taken into account by subtracting the avian tuberculin response from the bovine tuberculin response. At a specificity of 90.7%, the test was 70.6% sensitive. At the same specificity, the current serological enzyme-linked immunosorbent assay for TB in badgers was only 53% sensitive. This work demonstrates that measurement of IFN-γ mRNA by real-time PCR is a valid method for the detection of TB in live badgers and may provide an alternative to the current serological methods of diagnosis, the Brock test. The testing procedure can be completed within 5 h of receipt of the blood culture samples. In addition, the use of a molecular biology-based test offers the potential to fully automate the testing procedure through the use of robotics.
Journal of Clinical Microbiology | 2003
Tzvetelina Stefanova; Milliana Chouchkova; Jason Hinds; Philip D. Butcher; Jacqueline Inwald; James Dale; Si Palmer; R. Glyn Hewinson; Stephen V. Gordon
Mycobacterium bovis BCG remains the most widely used vaccine in the world, with a range of substrains that are named after their locations of production. More than 40 million doses of the BCG substrain Sofia are distributed annually through the United Nations Children’s Fund (UNICEF) and the Pan American Health Organization (PAHO) to approximately 120 different countries. However, in spite of its widespread use BCG Sofia has never been investigated at the genetic level, raising questions as to its genetic stability and exact provenance. The Bulgarian BCG Laboratory was established in 1949 when Dr. Srebra Rodopska obtained the BCG strain from the Institute Pasteur. However, due to suppurative cervical lymphadenitis in about 1% of orally vaccinated newborns, a few years later it was replaced with the Russian BCG strain. During 1972 lot 222 was approved as a master seed lot, originating the BCG substrain Sofia SL222. A working seed lot was produced from the master in 1993 from which all commercial lots are currently produced. To investigate the genetic properties of BCG Sofia, including its position on the BCG genealogical tree developed by Behr and colleagues (1), we performed genotyping assays on the master and working seed lots and on commercial batches no. 906 and 909 of BCG Sofia. We initially concentrated on genomic loci that are prone to variation. Spoligotyping exploits a polymorphic direct repeat (DR) locus that is composed of multiple 36-bp DR copies interspersed by unique spacers, with strains varying in the presence or absence of spacers (4). No difference among any of the BCG Sofia lots tested was found, with all strains showing patterns identical to those of other BCGs. Variable number of tandem repeat (VNTR) typing targeted six alleles (A through F [2]) that vary in the length and number of repeats at each target; i.e., 7-5-5-4-3-3 would have 7 copies of allele A, 5 of B, etc. (2). The VNTR profile of BCG Sofia was determined to be 5-5-5-2-3-3.1, which is identical to the profiles of all other BCG strains tested. A whole-genome analysis of BCG Sofia was undertaken by using M. tuberculosis microarrays (5). This disclosed a range of deletions and a duplication that places BCG Sofia in the same lineage as BCG Russia, in accordance with the BCG genealogy. However, a novel 1.6-kb deletion that affects the Rv3697c and Rv3698 homologues was revealed. To determine whether this deletion had occurred during in vitro propagation of BCG Sofia, we screened for this region in other BCG strains. The region was also deleted in BCG Russia but not in any other strain. Hence, this deletion occurred prior to the in vitro cultivation of BCG Sofia. Public concern over the safety of various vaccines demands that they should be described in exquisite detail (3). Our analyses show that BCG Sofia and BCG Russia are indistinguishable, although this does not preclude the existence of single nucleotide changes between the strains. We have therefore confirmed the genetic identity and provenance of a BCG vaccine that is given to over 40 million individuals a year.
Frontiers in Cellular and Infection Microbiology | 2017
Mark A. Chambers; Frank E. Aldwell; Gareth A. Williams; Si Palmer; Sonya Gowtage; Roland Ashford; Deanna Dalley; Dipesh Davé; U. Weyer; F.J. Salguero; Alejandro Núñez; Allan K. Nadian; T. R. Crawshaw; Leigh A. L. Corner; Sandrine Lesellier
The European badger (Meles meles) is a reservoir host of Mycobacterium bovis and responsible for a proportion of the tuberculosis (TB) cases seen in cattle in the United Kingdom and Republic of Ireland. An injectable preparation of the bacillus Calmette-Guérin (BCG) vaccine is licensed for use in badgers in the UK and its use forms part of the bovine TB eradication plans of England and Wales. However, there are practical limitations to the widespread application of an injectable vaccine for badgers and a research priority is the development of an oral vaccine deliverable to badgers in bait. Previous studies reported the successful vaccination of badgers with oral preparations of 108 colony forming units (CFU) of both Pasteur and Danish strains of BCG contained within a lipid matrix composed of triglycerides of fatty acids. Protection against TB in these studies was expressed as a reduction in the number and apparent progression of visible lesions, and reductions in the bacterial load and dissemination of infection. To reduce the cost of an oral vaccine and reduce the potential for environmental contamination with BCG, it is necessary to define the minimal efficacious dose of oral BCG for badgers. The objectives of the two studies reported here were to compare the efficacy of BCG Danish strain in a lipid matrix with unformulated BCG given orally, and to evaluate the efficacy of BCG Danish in a lipid matrix at a 10-fold lower dose than previously evaluated in badgers. In the first study, both BCG unformulated and in a lipid matrix reduced the number and apparent progression of visible lesions and the dissemination of infection from the lung. In the second study, vaccination with BCG in the lipid matrix at a 10-fold lower dose produced a similar outcome, but with greater intra-group variability than seen with the higher dose in the first study. Further research is needed before we are able to recommend a final dose of BCG for oral vaccination of badgers against TB or to know whether oral vaccination of wild badgers with BCG will significantly reduce transmission of the disease.
Journal of Clinical Microbiology | 2003
Jacqueline Inwald; Jason Hinds; Si Palmer; James Dale; Philip D. Butcher; R. G. Hewinson; Stephen V. Gordon
ABSTRACT The genomes of the tuberculin production strains Mycobacterium bovis AN5 and Mycobacterium tuberculosis DT were compared to genome-sequenced tubercle bacilli by using DNA microarrays. Neither the AN5 nor DT strain suffered extensive gene deletions during in vitro passage. This suggests that bovine tuberculin made from M. bovis AN5 is suitable to detect infection with presently prevalent M. bovis strains.
Letters in Applied Microbiology | 2013
R.M. Jones; Roland Ashford; J. Cork; Si Palmer; E. Wood; P. Spyvee; S. Parks; A. Bennett; Jacky Brewer; Richard J. Delahay; Mark A. Chambers; J. Sawyer
Environmental air sampling was evaluated as a method to detect the presence of M. bovis in the vicinity of infected badgers and their setts. Airborne particles were collected on gelatine filters using a commercially available air sampling instrument and tested for the presence of M. bovis using bacteriological culture and real‐time PCR. The sensitivity of bacteriological culture was broadly similar to that of real‐time PCR when testing samples artificially spiked with M. bovis. Sampling was undertaken from directly under the muzzles of badgers which had been experimentally infected with M. bovis (37 samples), within enclosures housing the experimentally infected animals (50 samples), and in the vicinity of setts with resident infected wild badgers (52 samples). The methods employed did not detect M. bovis from either infected badgers or artificial or natural setts known to contain infected animals. However, samples taken at four of the six natural setts were positive for Mycobacterium gordonae.